These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12224817)

  • 1. Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Circ J; 2002 Sep; 66(9):811-5. PubMed ID: 12224817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Jpn Circ J; 2001 Sep; 65(9):775-8. PubMed ID: 11548874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
    Zhuo JL; Mendelsohn FA; Ohishi M
    Hypertension; 2002 Feb; 39(2 Pt 2):634-8. PubMed ID: 11882622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
    Xiong Y; Lei M; Fu S; Fu Y
    Life Sci; 2005 May; 77(2):149-59. PubMed ID: 15862600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
    Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
    Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus.
    Kawata T; Daimon M; Hasegawa R; Teramoto K; Toyoda T; Sekine T; Yamamoto K; Uchida D; Himi T; Yoshida K; Komuro I
    Int J Cardiol; 2009 Feb; 132(2):286-8. PubMed ID: 18083252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story.
    Ferrari R; Fox K
    Drugs; 2009; 69(3):265-77. PubMed ID: 19275271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice.
    Akishita M; Shirakami G; Iwai M; Wu L; Aoki M; Zhang L; Toba K; Horiuchi M
    J Hypertens; 2001 Jun; 19(6):1083-8. PubMed ID: 11403357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
    Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus].
    Dotsenko VL; Demidova TIu; Neshkova EA; Ametov AS; Iarovaia GA
    Vopr Med Khim; 1998; 44(2):203-12. PubMed ID: 9634724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats.
    Toblli JE; Cao G; DeRosa G; Di Gennaro F; Forcada P
    Am J Hypertens; 2004 Feb; 17(2):172-80. PubMed ID: 14751661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
    Ceconi C; Fox KM; Remme WJ; Simoons ML; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R; ;
    Cardiovasc Res; 2007 Jan; 73(1):237-46. PubMed ID: 17140552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
    Maas R
    Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
    Janczak-Bazan A
    Ann Acad Med Stetin; 2006; 52(1):51-61; discussion 61-2. PubMed ID: 17131847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
    Bak JF; Gerdes LU; Sørensen NS; Pedersen O
    Am J Med; 1992 Apr; 92(4B):69S-72S. PubMed ID: 1580283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.
    Triches CB; Mayer S; Quinto BMR; Batista MC; Zanella MT
    J Clin Hypertens (Greenwich); 2018 May; 20(5):935-941. PubMed ID: 29604155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.